Evidence map›Paper›PMID 28984428›Full record

ReviewTransboundary and emerging diseases2018

Fasciola and fasciolosis in ruminants in Europe: Identifying research needs.

N J Beesley, C Caminade, J Charlier, R J Flynn, J E Hodgkinson, A Martinez-Moreno, M Martinez-Valladares, J Perez, L Rinaldi, D J L Williams

Open access · hybridAbstract readReview
In one paragraph

Review in Transboundary and emerging diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 3 pooled it
23.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 3 syntheses or guidelines pooled it, 209 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identification ofFrontiers in parasitology · 2026
    Article
  12. Timing ofFrontiers in immunology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Evaluation ofVaccines · 2025
    Article
  17. Natural Infection byAnimals : an open access journal from MDPI · 2025
    Article
  18. Article
  19. Article
  20. First report ofJournal of veterinary research · 2025
    Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

N J BeesleyInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
C CaminadeInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
J CharlierAvia-GIS, Zoersel, Belgium.
R J FlynnInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
J E HodgkinsonInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
A Martinez-MorenoUniversidad de Cordoba, Cordoba, Spain.
M Martinez-ValladaresInstituto de Ganaderia de Montana, CSIC Universidad de Leon, Grulleros, Leon, Spain.
J PerezUniversidad de Cordoba, Cordoba, Spain.
L RinaldiDepartment of Veterinary Medicine and Animal Productions, University of Naples Federico II, Napoli, Italy.
D J L WilliamsInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.ORCID http://orcid.org/0000-0001-8186-7236
University of Liverpool · GBUniversity of Córdoba · ESAvia-GIS (Belgium) · BEInstituto de Ganadería de Montaña · ESUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fasciola hepatica is a trematode parasite with a global distribution, which is responsible for considerable disease and production losses in a range of food producing species. It is also identified by WHO as a re-emerging neglected tropical disease associated with endemic and epidemic outbreaks of disease in human populations. In Europe, F. hepatica is mostly associated with disease in sheep, cattle and goats. This study reviews the most recent advances in our understanding of the transmission, diagnosis, epidemiology and the economic impact of fasciolosis. We also focus on the impact of the spread of resistance to anthelmintics used to control F. hepatica and consider how vaccines might be developed and applied in the context of the immune-modulation driven by the parasite. Several major research gaps are identified which, when addressed, will contribute to providing focussed and where possible, bespoke, advice for farmers on how to integrate stock management and diagnosis with vaccination and/or targeted treatment to more effectively control the parasite in the face of increasing the prevalence of infection and spread of anthelmintic resistance that are likely to be exacerbated by climate change.

Indexed as

AnimalsAnthelminticsCattleCattle DiseasesCommunicable Diseases, EmergingEuropeFasciola hepaticaFascioliasisGoat DiseasesGoatsHumansPrevalenceRuminantsSheepSheep DiseasesVaccinationAnthelminticsdiagnosisFasciola hepaticaflukefluke vaccineflukicide resistanceGalbahelminth immunomodulationresearch gapssocio-economics of parasite infectiontransmission

Identifiers

PMID28984428
PMCPMC6190748
OpenAlexW2763453594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.